WO2024184924 - "AN IMPROVED PROCESS FOR THE PREPARATION OF ODEVIXIBAT AND ITS CRYSTALLINE FORMS"
National phase entry is expected:
Publication Number
WO/2024/184924
Publication Date
12.09.2024
International Application No.
PCT/IN2024/050229
International Filing Date
05.03.2024
Title **
[English]
"AN IMPROVED PROCESS FOR THE PREPARATION OF ODEVIXIBAT AND ITS CRYSTALLINE FORMS"
[French]
PROCÉDÉ AMÉLIORÉ POUR LA PRÉPARATION D'ODEVIXIBAT ET DE SES FORMES CRISTALLINES
Applicants **
RK PHARMA INC
RK Pharma Inc., 401 N Middletown Rd Building 215/215A, Pearl River, NY 10965, United States of America
New York, New York, US
APICORE PHARMACEUTICALS PRIVATE LIMITED
Apicore Pharmaceuticals Private Limited
4th and 5th floor, Sri Lakshmi Spaces, Plot no 7, Kavuri hills, Phase 1, Madhapur, Hyderabad, Telangana State, India- 500033
Hyderabad 500033, IN
Inventors
KOVI, Ravishanker
685 US Highway 1 South 2nd Floor North Brunswick, NJ 08902
New York, New York, US
KANNAPPAN, Jayraman
Apicore Pharmaceuticals Private Limited, Block No. 252-253, Opposite Jain Irrigation Company, Padra-Jambusar Highway, Taluka Padra, Village Dhobikuva, Vadodara-391440
Vadodara 391440, IN
DUSANAPUDI, Naga Venkata Raghavulu
Apicore Pharmaceuticals Private Limited, Block No. 252-253, Opposite Jain Irrigation Company, Padra-Jambusar Highway, Taluka Padra, Village Dhobikuva, Vadodara-391440
Vadodara 391440, IN
PUNUGUPATI, Suresh Kumar
Apicore Pharmaceuticals Private Limited, Block No. 252-253, Opposite Jain Irrigation Company, Padra-Jambusar Highway, Taluka Padra, Village Dhobikuva, Vadodara-391440
Vadodara 391440, IN
HIWARE, Pradip
Apicore Pharmaceuticals Private Limited, Block No. 252-253, Opposite Jain Irrigation Company, Padra-Jambusar Highway, Taluka Padra, Village Dhobikuva, Vadodara-391440
Vadodara 391440, IN
DONTHUKURTHI, Sai Suryanarayana
Apicore Pharmaceuticals Private Limited, Block No. 252-253, Opposite Jain Irrigation Company, Padra-Jambusar Highway, Taluka Padra, Village Dhobikuva, Vadodara-391440
Vadodara 391440, IN
Priority Data
202341015015
06.03.2023
IN
202341029309
22.04.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1449 | |
| EPO | Filing, Examination | 9333 | |
| Japan | Filing | 538 | |
| South Korea | Filing | 608 | |
| USA | Filing, Examination | 6835 |
Total: 18763 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to Odevixibat and improved process for the preparation thereof The present invention also provides improved processes for the preparation of Odevixibat KSM 2-butyl-N-1-phenyl-hexane-1,2-diamine. The present invention also relates to a process for the preparation of dipeptide intermediate compound of Formula VIII. The present invention relates to crystalline form of Odevixibat and process for preparation of thereof.[French]
La présente invention concerne l'odevixibat et un procédé amélioré pour la préparation de celui-ci. La présente invention concerne également des procédés améliorés pour la préparation d'ovixibat KSM 2-butyl-N-1-phényl-hexane-1,2-diamine. La présente invention concerne également un procédé de préparation d'un composé intermédiaire dipeptidique représenté par la formule VIII. La présente invention concerne une forme cristalline de l'odevixibat et son procédé de préparation.